According to Alaunos Therapeutics's latest financial reports the company's current earnings (TTM) are -$33.22 M. an increase over its 2022 earnings that were of -$34.58 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$33.22 M | -3.93% |
2022 | -$34.58 M | -55.43% |
2021 | -$77.59 M | -3.46% |
2020 | -$80.37 M | 38.89% |
2019 | -$57.86 M | 7.33% |
2018 | -$53.91 M | 0.77% |
2017 | -$53.5 M | -67.64% |
2016 | -$0.17 B | 37.64% |
2015 | -$0.13 B | 176.1% |
2014 | -$43.5 M | -24.63% |
2013 | -$57.72 M | |
2011 | -$71.4 M | 190.88% |
2010 | -$24.55 M | 102.46% |
2009 | -$12.13 M | -52.68% |
2008 | -$25.62 M | -10.33% |
2007 | -$28.58 M | 15.35% |
2006 | -$24.77 M | |
2004 | -$1.39 M | 3769.83% |
2003 | -$0.04 M | -10.26% |
2002 | -$0.04 M | -62.16% |
2001 | -$0.11 M |